ANI Pharmaceuticals (ANIP) Financials

$70.23

$-1.00 (-1.40%)

As on 08-Sep-2026 16:00EDT

Market cap

$1,636 Mln

Revenue (TTM)

$978 Mln

P/E Ratio

15.5

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	978.38	883.37	614.38	486.82	316.39	216.14
Cost of Revenue	340.18	432.73	250.21	181.51	138.79	100.61
Gross Profit	638.20	450.64	364.17	305.30	177.60	115.53
Operating Expenses	488.03	369.41	363.58	258.33	212.88	155.32
Operating Profit (EBIT)	150.17	81.23	0.58	46.97	-35.28	-39.79
Other Income	--	--	--	--	0.67	-4.34
Profit before Tax	142.60	95.79	-22.21	19.87	-62.67	-56.06
Provision for Tax	34.29	17.45	-3.69	1.09	-14.77	-13.46
Profit after Tax (Net Income)	105.83	78.34	-18.52	18.78	-47.90	-42.60
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-49.52	-42.79

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	597.21	540.72	428.53	457.60	338.54	358.74
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	613.25	621.54	661.49	301.35	322.11	325.32
Current Liabilities	283.66	278.11	193.68	145.48	99.44	87.54
Total Liabilities	1,777.77	1,440.38	1,283.70	904.42	760.09	771.60

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	668.68	687.26	756.01	384.61	415.83	449.82
Current Assets	825.43	753.12	527.68	519.82	344.26	321.78
Total Assets	1,777.77	1,440.38	1,283.70	904.42	760.09	771.60
Total Debt*	330.34	325.20	624.09	285.67	286.52	287.37
Net Current Assets	541.78	475.01	334.00	374.34	244.82	234.24

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	185.23	64.02	118.96	-31.20	3.32
Cash Flow from Investing Activities	--	-34.32	-404.72	-18.51	-15.74	-105.48
Cash from Financing Activities	--	-9.94	264.95	67.44	-5.13	194.60
Net Cash Inflow / Outflow	--	--	--	--	-52.07	92.43

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	4.94	3.69	-0.95	0.98	-2.93	-3.00
Cash EPS ($)	--	8.00	2.53	4.11	0.56	0.33
Adjusted Book Value ($)	--	25.47	22.04	23.81	20.74	25.29
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	8.73	3.29	6.19	-1.91	0.23
Free Cash Flow per Share ($)	--	7.11	2.42	5.23	-2.92	-1.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	8.17	-2.06	2.74	-7.54	-8.29
ROE (%)	18.60	16.16	-4.18	4.72	-13.74	-15.37
ROA (%)	6.30	5.75	-1.69	2.26	-6.25	-6.91
EBIT Margin (%)	17.38	13.11	-0.75	9.62	-10.94	-20.42
Net Margin (%)	10.82	8.87	-3.01	3.86	-15.11	-20.12
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	30.90	0.44	0.26	0.54	0.46	0.04
EBIT Growth (%)	3,661.75	2,613.04	-109.85	235.24	21.58	-167.33
Net Profit Growth (%)	1,136.30	522.94	-198.63	139.21	-12.42	-88.94
EPS Growth (%)	964.90	4.87	-1.97	1.33	0.02	-0.60
Book Value Growth (%)	19.89	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	15.52	21.39	-58.03	56.43	-13.71	-15.34
Price / Book Value	2.77	3.10	2.51	2.32	1.94	1.82
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	7.71	8.23	24.52	10.55	35.74	269.82
Close Price ($)	82.78	78.94	55.28	55.14	40.23	46.08
High Price ($)	99.50	99.50	70.81	65.89	48.26	60.23
Low Price ($)	62.61	52.74	52.50	36.54	22.31	26.10
Market Cap ($ Cr)	1,636.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.99	0.60	1.46	0.62	0.85	0.80
Short term debt to equity ratio	0.04	0.03	0.02	0.00	0.00	0.00
Current Ratio	2.91	2.71	2.72	3.57	3.46	3.68
Quick Ratio	2.41	2.19	2.02	2.81	2.40	2.74
Interest Coverage	5.08	5.78	-0.26	1.74	-1.23	-3.70

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	28.05	31.82	36.09	33.29	52.29	59.47
Asset Turnover	0.58	0.65	0.56	0.58	0.41	0.35
Receivable days	--	103.95	114.09	122.87	169.68	189.54
Inventory Days	--	118.11	181.00	217.88	246.13	258.66
Payable days	--	45.68	60.10	66.39	68.78	62.13
Cash Conversion Cycle	--	176.37	234.98	274.35	347.03	386.06

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.